Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
52,406,487
-
Total 13F shares
-
32,832,112
-
Share change
-
-1,098,879
-
Total reported value
-
$307,624,848
-
Put/Call ratio
-
26%
-
Price per share
-
$9.37
-
Number of holders
-
132
-
Value change
-
-$28,979,577
-
Number of buys
-
70
-
Number of sells
-
44
Institutional Holders of 2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT) as of Q4 2022
As of 31 Dec 2022,
2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT) was held by
132 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,832,112 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, BAKER BROS. ADVISORS LP, Casdin Capital, LLC, Bain Capital Life Sciences Investors, LLC, MILLENNIUM MANAGEMENT LLC, Madison Avenue Partners, LP, and EcoR1 Capital, LLC.
This page lists
132
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.